Human study · Supplements / medicine · 8 Sept 2026
Five midlife heart-risk checks tracked nearly 11 extra years and less frailty in Finnish men
Source: News-Medical
What the research found
Study (lifelong cohort). Timo Strandberg and University of Helsinki colleagues report in the European Journal of Preventive Cardiology (doi 10.1093/eurjpc/zwag429) on 2,690 initially healthy Helsinki Businessmen Study men first examined at mean age 42 (1964–1973) and followed through 31 January 2025 (93.8% died). Five low-risk items (non-smoker, BMI <25, systolic BP <140, cholesterol <6.0 mmol/L, one-hour post-load glucose <9.0) stacked: 41.9% of men with all five reached 90 versus 6.8% with none; age-adjusted survival after exam was 42.7 vs 31.8 years. At mean age 79, five-factor men had less frailty (2.2% vs 24.5%). Observational, men-only, high SES. Educational notes, not a reason to start or stop prescribed medicine.
Evidence level: Human study. A study in people, but an association isn't proof of cause.
More supplements / medicine news
- In mice, the experimental drug KCL-286 reduced DNA breaks and brain inflammation in an Alzheimer's model
- In aged rats, two weeks of the experimental drug cinaciguat cut circulating amyloid-beta about in half and brought LDL down to youthful levels
- In 104 people with a sudden retinal-artery blockage, papaverine use lined up with better functional vision in a retrospective comparison
- A Cell Metabolism letter questions whether a fasting GLP-1 level shows how many gut L-cells a person has
- In FDA reports, caffeine and stimulant supplement use was tied to cardiac arrest about 11 times more often, and 45 percent of those cardiovascular reports were ages 18 to 34